Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, ...
FDA Drug Recall #D-1495-2016 — Class II — June 17, 2016
Recall Summary
| Recall Number | D-1495-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 17, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Teva North America |
| Location | Horsham, PA |
| Product Type | Drugs |
| Quantity | 92,480 containers |
Product Description
Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers)
Reason for Recall
CGMP Deviations
Distribution Pattern
Nationwide and Puerto Rico
Lot / Code Information
All Lots Within Expiry
Other Recalls from Teva North America
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0005-2017 | Class III | Claravis (isotretinoin capsules USP), 10mg, pa... | Aug 5, 2016 |
| D-1453-2016 | Class III | Children's Qnasl 40 mcg (beclomethasone dipropi... | Jul 15, 2016 |
| D-1470-2016 | Class II | Amoxicillin for Oral Suspension USP, 400 mg/ 5 ... | Jun 24, 2016 |
| D-1455-2016 | Class II | Albuterol Sulfate Syrup, 2 mg/ 5 mL, 473 mL bot... | Jun 22, 2016 |
| D-1494-2016 | Class II | ARGATROBAN Injection in 0.9% Sodium Chloride 25... | Jun 17, 2016 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.